Literature DB >> 17212770

Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.

J M Low1, A K Chauhan, T L Moore.   

Abstract

Patients with juvenile idiopathic arthritis (JIA) have been shown to have elevated levels of circulating immune complexes (CICs) which correlated with disease activity. Our aim was to assess B cell activity by measuring the amount of and the kappa:lambda chain immunoglobulin light (L) chain ratio in CICs from JIA patients and to determine potential evidence for either an antigen-driven response or B-cell receptor editing. We used an enzyme-linked immunosorbent assay to measure kappa and lambda chains present in the CICs from the sera of patients with JIA. Statistical analysis was performed using Pearson's correlation, one-way ANOVA and Bonferroni post hoc analysis. Sera from 44 JIA patients were examined for the concentration of L chains in CICs. Healthy controls had a kappa:lambda chain ratio of 1.2:1, whereas this ratio was reversed among JIA subgroups with RF-positive polyarthritis (1:1.2), RF-negative polyarthritis (1:1.3), oligoarthritis (1:2.3) and systemic-onset arthritis (1:2.5). In addition, overall lambda chain selection was not significantly associated with a particular immunoglobulin heavy (H) chain and occurred with all immunoglobulin isotypes. We showed preferential selection of lambda chains contributing to the formation of potentially pathogenic CICs from JIA patients, of all onset types compared to healthy controls, in an H chain-independent manner. The reversal of kappa:lambda chain ratio within the JIA CICs and association with all immunoglobulin isotypes demonstrated the potential for L chain editing. Furthermore, we conclude that a reversal of the normal kappa:lambda chain ratio in JIA CICs may be used as a marker for increased B-cell activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17212770     DOI: 10.1111/j.1365-3083.2006.01859.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Up regulated complement and fc receptors in juvenile idiopathic arthritis and correlation with disease phenotype.

Authors:  Kajsa E Prokopec; Lillemor Berntson; Anders Öman; Sandra Kleinau
Journal:  J Clin Immunol       Date:  2012-02-11       Impact factor: 8.317

Review 2.  Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology.

Authors:  Reema H Syed; Brooke E Gilliam; Terry L Moore
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

3.  B-cell pathology in juvenile idiopathic arthritis.

Authors:  V Wiegering; H J Girschick; H Morbach
Journal:  Arthritis       Date:  2010-12-02

Review 4.  Immune Complexes in Juvenile Idiopathic Arthritis.

Authors:  Terry L Moore
Journal:  Front Immunol       Date:  2016-05-20       Impact factor: 7.561

Review 5.  Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.

Authors:  Shawn A Mahmud; Bryce A Binstadt
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

Review 6.  B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.

Authors:  Meredyth G Ll Wilkinson; Elizabeth C Rosser
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

7.  Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.

Authors:  Linda M Slot; Rochelle D Vergroesen; Priscilla F Kerkman; Ellen Staudinger; Sanne Reijm; Hugo J van Dooren; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes; Hans U Scherer
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

Review 8.  B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

Authors:  Rita A Moura; João Eurico Fonseca
Journal:  Front Med (Lausanne)       Date:  2022-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.